QVIDTVM Management LLC
In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 13, 2024), QVIDTVM Management LLC reported 8 stock positions worth $142.9 million. Its top holding was Bio-Rad Laboratories-A (BIO) at 29.5% of the portfolio, followed by Solventum (SOLV, 24.3%) and Wabtec (WAB, 13.8%). Compared with Q2 2024, it opened 1 new position, added to 3 and reduced 2. The biggest buy was Solventum (SOLV, shares +13%) and the biggest sale Rentokil Initial PLC-SP ADR (RTO, shares −16%).
- Most Recent 13F
- Q2 2026
- Location
- THE WOODLANDS, TX
- CIK
- 0001912226
- Portfolio Value
- $142.9M (Q3 2024)
- SEC Filing
- 0001912226-24-000006 ↗ filed Nov 13, 2024
Holdings Value
Holdings 8 stocks · $142.9M
| BIO Bio-Rad Laboratories-A | 29.49% | 125,938 | $42.1M | No change |
| SOLV Solventum Corp. | 24.27% | 497,276 | $34.7M | Add +13.5% |
| WAB Wabtec Corp. | 13.80% | 108,475 | $19.7M | Reduce -4.8% |
| RTO Rentokil Initial PLC-SP ADR | 13.09% | 750,176 | $18.7M | Reduce -15.6% |
| XRAY Dentsply Sirona Inc. | 8.69% | 458,866 | $12.4M | Add +75.8% |
| BRC INC-A | 7.71% | 3,219,929 | $11.0M | Add +24.2% |
| ZGN Ermenegildo Zegna NV | 2.04% | 295,562 | $2.9M | New |
| OMIC Singular Genomics Systems Inc. | 0.92% | 83,558 | $1.3M | No change |
Portfolio Sells Q2 2024 → Q3 2024
Portfolio Buys Q2 2024 → Q3 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 14 | $76.6M | BIO, NBIS, AMRZ, ORCL, SOLV |
| Q1 2026 | 14 | $81.4M | BIO, SOLV, AMRZ, NBIS, ORCL |
| Q4 2025 | 13 | $88.4M | BIO, SOLV, AMRZ, XRAY, ZGN |
| Q3 2025 | 8 | $92.9M | SOLV, BIO, COTY, XRAY, BRC INC-A |
| Q2 2025 | 8 | $99.8M | SOLV, BIO, COTY, XRAY, RTO |
| Q1 2025 | 8 | $113.1M | SOLV, BIO, RTO, COTY, XRAY |
| Q4 2024 | 8 | $124.2M | BIO, SOLV, RTO, BRC INC-A, XRAY |
| Q3 2024 | 8 | $142.9M | BIO, SOLV, WAB, RTO, XRAY |
| Q2 2024 | 7 | $125.0M | BIO, RTO, SOLV, WAB, BRC INC-A |
| Q1 2024 | 10 | $124.2M | BIO, RTO, WAB, BRC INC-A, XRAY |